Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), the Registrar and Transfer Agent of Company Karvy Fintech has received requests for issue of duplicate Share Certificates from Shareholder.
The above information is a part of company’s filings submitted to BSE.